Parul Jayakar
Clinical Genetics (M.D.) · Miami, FLNPI 1881651396
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $64,161 of the $81,562 with a category attached, or 78.7%. Sanofi accounts for 94.7% of it on its own, with 25 other manufacturers making up the rest. Among clinical genetics (m.d.) clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 186 payments — averaging $438.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$77K
- Amgen$1K
- NS Pharma, Inc.$493
- Biomarin Pharmaceutical Inc.$396
- SK Life Science, Inc.$289
- Ultragenyx Pharmaceutical Inc.$261
- plus $1K from 20 others
Across 2 payments — averaging $22,857 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Modernatx, Inc.$24K
- Chiesi USA, Inc.$22K
What the payments were for
- Speaking & faculty fees$64,16179%
- Travel & lodging$12,35915%
- Food & beverage$5,0056%
- Education$390%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 83 | $77,228 |
| Amgen | 1 | $1,400 |
| NS Pharma, Inc. | 20 | $493 |
| Biomarin Pharmaceutical Inc. | 15 | $396 |
| SK Life Science, Inc. | 14 | $289 |
| Ultragenyx Pharmaceutical Inc. | 6 | $261 |
| Travere Therapeutics, Inc. | 6 | $221 |
| Amicus Therapeutics, Inc. | 3 | $203 |
| Acadia Pharmaceuticals Inc | 6 | $145 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $117 |
| Sarepta Therapeutics, Inc. | 2 | $112 |
| Chiesi USA, Inc. | 3 | $112 |
| Mirum Pharmaceuticals, Inc. | 4 | $108 |
| Intrabio Inc | 1 | $88 |
| Cycle Pharmaceuticals Inc | 3 | $55 |
| AstraZeneca | 2 | $55 |
| Ipsen Biopharmaceuticals, Inc | 2 | $46 |
| Supernus Pharmaceuticals, Inc. | 2 | $39 |
| UCB, Inc. | 1 | $34 |
| PTC Therapeutics, Inc. | 1 | $31 |
| Springworks Therapeutics, Inc. | 1 | $29 |
| Immedica Pharma US, Inc. | 1 | $24 |
| Albireo Pharma, Inc. | 1 | $24 |
| Sentynl Therapeutics, Inc. | 1 | $21 |
| Biogen | 1 | $19 |
| Aprecia Pharmaceuticals, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$81,562 in reported general payments places this provider in the 90th percentile of 37 clinical genetics (m.d.) providers in Florida.
Other clinical genetics (m.d.) in Miami
- Deborah BarbouthMiami$40K
- Irman ForghaniMiami$3K
- Sajel LalaMiami$2K
- Ana Marie Rodriguez BarretoMiami$1K
- Thelma SugranesMiami$1K
- Paul CardenasMiami$343
- Sofia CatenaMiami$229
- Willa ThorsonMiami$71
- Mustafa TekinMiami$52
- Nicholas BorjaMiami$41
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.